• Sales reached € 18,337 million, down by 2.6% mainly due to COVID-19. • EBITDA reached € 1,345 million, down by 17% due to Abertis’ negative contribution related to COVID-19; not considering this impact EBITDA was down by 6.8%. • Net profit was also affected by Abertis and decreased by 30.9%. Not considering this impact, the Group’s net profit shrank by 5.1%. • Backlog stood at € 75,812 million, similar to that of twelve months ago.